Innominds & Celegence partner to drive AI-powered regulatory innovation in life sciences

Bengaluru, 18 June

Innominds, a leading product engineering firm, has announced a strategic partnership with Celegence, a provider of regulatory affairs services and solutions for the life sciences industry. The alliance is set to deliver integrated, AI-powered solutions that streamline regulatory compliance and accelerate digital innovation for pharmaceutical, biotechnology, and medical device companies worldwide, the company said in a press release.

This partnership brings together Innominds’ deep expertise in AI, IoT, and advanced analytics with Celegence’s strong domain knowledge in regulatory affairs and its proprietary CAPTIS® AI platform.

“Our partnership with Celegence is a testament to our commitment to enabling the digital future of life sciences,” said Divakar Tantravahi, CEO, Innominds. “Together, we will help clients harness the power of Device engineering, AI and data to navigate the complexities of regulatory processes with greater agility and intelligence.”

“This collaboration aligns perfectly with our vision of transforming regulatory affairs through cutting-edge technology,” said Sonia Veluchamy, CEO, Celegence. “With Innominds’ digital engineering capabilities and our regulatory acumen, we aim to deliver measurable value to our clients by accelerating innovation while maintaining compliance.”